Gapping up
In reaction to earnings/guidance:
- AYI +1.7%
Other news:
- PLTR +8.3% (selected by US Army for intelligence systems and analytics)
- STIM +7.9% (announces commercial agreement with Success TMS)
- ONCT +5.9% (announces pre-clinical data from ONCT-534 was accepted for presentation)
- CLXT +5.1% (announces new initiative to provide plant-based synthetic biology solutions to expanded end markets)
- RDHL +4.3% (Medi-Cal adds Talicia as contract drug)
- VXX +4% (trading higher with early weakness in US futures)
- NWPX +2.1% (acquires ParkUSA for $87.4 mln)
- IRTC +1% (Zio demonstrates improved health outcomes in clinical trial)
Analyst comments:
- ABEV +1.1% (upgraded to Overweight from Equal Weight at Barclays)